Conducting Phase I Trials During the SARS-Coronavirus-2 Outbreak: About Science and Care
Main Authors: | Angelo Dipasquale, Pasquale Persico, Elena Lorenzi, Monica Bertossi, Armando Santoro, Matteo Simonelli |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2020-05-01
|
Series: | Frontiers in Oncology |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fonc.2020.00926/full |
Similar Items
-
Guidance to post-mortem collection and storage of biological specimens for the diagnosis of Covid-19 infection
by: Francesco d'Aleo, et al.
Published: (2020-08-01) -
COVID-19 lung injury as a primer for immune checkpoint inhibitors (ICIs)-related pneumonia in a patient affected by squamous head and neck carcinoma treated with PD-L1 blockade: a case report
by: Matteo Simonelli, et al.
Published: (2021-02-01) -
Checkpoint Inhibitors as High-Grade Gliomas Treatment: State of the Art and Future Perspectives
by: Pasquale Persico, et al.
Published: (2021-03-01) -
Subacute Thyroiditis – literature overview and COVID-19
by: Remigiusz Domin, et al.
Published: (2020-12-01) -
Children with COVID-19 behaving milder may challenge the public policies: a systematic review and meta-analysis
by: Chan Liu, et al.
Published: (2020-09-01)